A round of Series AA venture capital financing involving Boston Scientific has brought in $20 million for Willoughby Hills, Ohio-based neuromodulation company Neuros Medical. The proceeds will be used for the completion of an initial pivotal investigational device exemption study of the company's Altius System High Frequency Nerve Block technology for post-amputation pain management, as well as to obtain FDA premarket approval.
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.